A double-blind placebo-controlled study of OKY-046 for the treatment of chronic asthma.
Kabe
J
J
D000179:Acrylates / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000652:urine; D002908:Chronic Disease; D004311:Double-Blind Method; D006801:Humans; D008689:Methacrylates / Q000627:therapeutic use*; D013929:Thromboxane B2 / Q000652:urine / Q000031:analogs & derivatives; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors
D000179:Acrylates; D008689:Methacrylates; D013929:Thromboxane B2; C028965:2,3-dinor-thromboxane B2; D013930:Thromboxane-A Synthase; C034364:ozagrel